Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Study ID: NCT06846320
Start Date: 2025-05-13
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

315

Intervention / Treatment

Abbv-932

Placebo for ABBV-932

Antidepressant Therapy (ADT)

Sponsor

AbbVie

Source: clinicaltrials.gov

Share:
Add to list

ITBS for Alcohol Use Disorder

Study ID: NCT06696365
Start Date: 2025-04-30
End Date: 2027-02-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

42

Intervention / Treatment

TMS

Sponsor

Nicholas Balderston, PhD

Source: clinicaltrials.gov

Share:
Add to list

Early Intervention

Study ID: NCT05326165
Start Date: 2025-05
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Juzo Compression Sleeve and Glove

Compression Sleeve Sensor

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Sympathetic Vascular Transduction Across the Menopause Transition: Contributing Mechanisms

Study ID: NCT06787066
Start Date: 2025-05
End Date: 2026-12
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

75

Intervention / Treatment

Propranolol Hydrochloride

Phentolamine Injection

Sponsor

University of Missouri-Columbia

Source: clinicaltrials.gov

Share:
Add to list

Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia®

Study ID: NCT06504966
Start Date: 2025-10
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

440

Intervention / Treatment

MAB-22

Prolia®

Sponsor

Xentria, Inc.

Source: clinicaltrials.gov

Share:
Add to list

ELISA in Relapsed/Refractory MM

Study ID: NCT06832865
Start Date: 2026-08-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Follower

Isatuximab SC

Isatuximab SC-OBDS

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Trunk and Upper Extremities Program Effect in Decreasing Compensation Patterns in Unilateral Cerebral Palsy Children

Study ID: NCT06069765
Start Date: 2025-09
End Date: 2027-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

TUPEX

Sponsor

FUNDACIO ASPACE CATALUNYA

Source: clinicaltrials.gov

Share:
Add to list

Towards Digital Management of Paediatric Asthma

Study ID: NCT06902766
Start Date: 2025-10
End Date: 2026-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Telemonitoring system relying on the use of 2 digital inhalers FindAir ONE for pMDI, one for the controller the other for the reliever treatment

Sponsor

Public assistance - Paris hospitals

Source: clinicaltrials.gov

Share:
Add to list

Social Cognition in Dystrophinopathies and Neurodevelopmental Disorders

Study ID: NCT06874166
Start Date: 2025-09
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

45

Intervention / Treatment

Electroencephalography (EEG)

Social Cognition Tasks

Sponsor

IRCCS Eugenio Medea

Source: clinicaltrials.gov

Share:
Add to list

Esophageal Manometry During Recovery From Endotracheal Intubation

Study ID: NCT05574465
Start Date: 2025-07-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

High resolution solid state manometry

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list